Drug Shortage Report for MOXIFLOXACIN INJECTION
Report ID | 115558 |
Drug Identification Number | 02433087 |
Brand name | MOXIFLOXACIN INJECTION |
Common or Proper name | Moxifloxacin Injection 400mg/250ml |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | MOXIFLOXACIN |
Strength(s) | 400MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 250 ml |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-05-21 |
Actual start date | 2020-05-21 |
Estimated end date | Unknown |
Actual end date | 2020-06-12 |
Shortage status | Resolved |
Updated date | 2020-06-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-06-13 | English | Compare |
v6 | 2020-06-12 | French | Compare |
v5 | 2020-06-12 | English | Compare |
v4 | 2020-05-22 | English | Compare |
v3 | 2020-05-21 | French | Compare |
v2 | 2020-05-21 | English | Compare |
v1 | 2020-05-21 | English | Compare |
Showing 1 to 7 of 7